AAPL Apple | Target Raised by | UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $224.13 0.0% | $236.00 | Hold | |
ABBV AbbVie | Target Lowered by | Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $175.63 +0.7% | $231.00 ➝ $224.00 | Overweight ➝ Overweight | |
ABNB Airbnb | Reiterated by | Phillip Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $134.37 -2.2% | $120.00 | Neutral ➝ Reduce | |
ADM Archer-Daniels-Midland | Target Lowered by | Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $51.81 -1.1% | $57.00 ➝ $52.00 | Equal Weight ➝ Equal Weight | |
AESI Atlas Energy Solutions | Downgraded by | Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $21.43 -2.6% | $23.00 ➝ $19.00 | Overweight ➝ Equal Weight | |
AGYS Agilysys | Target Raised by | Oppenheimer Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $125.19 +1.9% | $120.00 ➝ $135.00 | Outperform ➝ Outperform | |
|
ALB Albemarle | Target Lowered by | KeyCorp Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $106.26 -3.8% | $132.00 ➝ $127.00 | Overweight ➝ Overweight | |
ALGM Allegro MicroSystems | Initiated by | Loop Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $20.78 -0.4% | $30.00 | Buy | |
ALNY Alnylam Pharmaceuticals | Downgraded by | Wolfe Research Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $267.47 -4.4% | | Peer Perform ➝ Underperform | |
ALT Altimmune | Initiated by | UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $8.54 +16.2% | $26.00 | Buy | |
ALXO ALX Oncology | Reiterated by | Cantor Fitzgerald Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $1.45 -2.0% | | Overweight | |
AMCX AMC Networks | Target Lowered by | Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $8.41 -3.8% | $10.00 ➝ $9.00 | Underweight ➝ Underweight | |
AMGN Amgen | Reiterated by | William Blair Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $320.12 -0.5% | | Outperform | |
ARDT Ardent Health Partners | Target Raised by | Leerink Partners Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $17.40 +0.5% | $23.00 ➝ $25.00 | Outperform ➝ Outperform | |
ARGX argenx | Upgraded by | Wolfe Research Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $595.80 +1.2% | $697.00 | Peer Perform ➝ Outperform | |
ARMK Aramark | Target Raised by | Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $38.51 -0.4% | $38.00 ➝ $40.00 | Equal Weight ➝ Equal Weight | |
ARMK Aramark | Target Raised by | Robert W. Baird Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $38.51 -0.4% | $38.00 ➝ $44.00 | Neutral ➝ Neutral | |
ATMU Atmus Filtration Technologies | Target Raised by | Robert W. Baird Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $42.71 +0.8% | $42.00 ➝ $48.00 | Outperform ➝ Outperform | |
AVAV AeroVironment | Downgraded by | Jefferies Financial Group Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $226.00 -3.9% | $240.00 ➝ $240.00 | Buy ➝ Hold | |
AVDL Avadel Pharmaceuticals | Reiterated by | Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $14.43 -11.5% | $22.00 ➝ $22.00 | Buy ➝ Buy | |
AXSM Axsome Therapeutics | Reiterated by | Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating | A. Fadia Subscribe to MarketBeat All Access for the recommendation accuracy rating | $100.80 +10.8% | $130.00 ➝ $130.00 | Buy ➝ Buy | |
BABA Alibaba Group | Target Raised by | Mizuho Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $92.84 -2.7% | $92.00 ➝ $113.00 | Outperform ➝ Outperform | |
BIDU Baidu | Target Lowered by | Mizuho Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $85.29 -3.4% | $130.00 ➝ $115.00 | Outperform ➝ Outperform | |
BILI Bilibili | Target Raised by | Mizuho Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $21.43 -5.8% | $17.00 ➝ $21.00 | Outperform ➝ Outperform | |
BJ BJ's Wholesale Club | Target Raised by | Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating | E. Kelly Subscribe to MarketBeat All Access for the recommendation accuracy rating | $88.39 -1.4% | $92.00 ➝ $100.00 | Overweight ➝ Overweight | |
BKE Buckle | Upgraded by | UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $47.83 +6.0% | $31.00 ➝ $46.00 | Sell ➝ Neutral | |
BLNK Blink Charging | Reiterated by | Benchmark Subscribe to MarketBeat All Access for the recommendation accuracy rating | M. Legg Subscribe to MarketBeat All Access for the recommendation accuracy rating | $1.75 -4.4% | $5.00 ➝ $5.00 | Buy ➝ Buy | |
BMY Bristol-Myers Squibb | Upgraded by | Leerink Partners Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $59.73 -0.2% | $55.00 ➝ $73.00 | Market Perform ➝ Outperform | |
BMY Bristol-Myers Squibb | Target Raised by | Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $59.73 -0.2% | $36.00 ➝ $39.00 | Underweight ➝ Underweight | |
BRX Brixmor Property Group | Target Raised by | KeyCorp Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $29.09 +0.4% | $28.00 ➝ $32.00 | Overweight ➝ Overweight | |
BWXT BWX Technologies | Upgraded by | Alembic Global Advisors Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $126.18 -0.3% | $148.00 | Neutral ➝ Overweight | |
CGON CG Oncology | Reiterated by | HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $38.62 -2.7% | $75.00 ➝ $75.00 | Buy ➝ Buy | |
CHRW C.H. Robinson Worldwide | Upgraded by | Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating | A. Rosa Subscribe to MarketBeat All Access for the recommendation accuracy rating | $109.97 +0.9% | $110.00 ➝ $127.00 | Neutral ➝ Buy | |
CMG Chipotle Mexican Grill | Reiterated by | Stephens Subscribe to MarketBeat All Access for the recommendation accuracy rating | J. Salera Subscribe to MarketBeat All Access for the recommendation accuracy rating | $60.24 +1.6% | $65.00 ➝ $65.00 | Equal Weight ➝ Equal Weight | |
CMPO CompoSecure | Reiterated by | Benchmark Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $14.12 -0.1% | $17.00 ➝ $17.00 | Buy ➝ Buy | |
CNI Canadian National Railway | Upgraded by | Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating | A. Rosa Subscribe to MarketBeat All Access for the recommendation accuracy rating | $112.32 +0.6% | $126.00 ➝ $130.00 | Neutral ➝ Buy | |
CRI Carter's | Upgraded by | Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $53.11 +0.8% | $50.00 ➝ $50.00 | Sell ➝ Neutral | |
CRUS Cirrus Logic | Initiated by | Loop Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $105.21 +0.5% | $130.00 | Buy | |
CTXR Citius Pharmaceuticals | Reiterated by | HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $0.47 +5.4% | $4.00 ➝ $4.00 | Buy ➝ Buy | |
CXM Sprinklr | Downgraded by | Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $8.16 -1.6% | $8.00 ➝ $6.00 | Equal Weight ➝ Underweight | |
Central Bank Abandons USD (Ad) Startling new evidence shows the U.S. Central Bank is abandoning the currency we’ve relied on for centuries – the United States Dollar…
And placing a ‘quiet bet’ on a new type of currency…
Gold.
Click here now to get your free 'Protect Your Wealth' Guide. |
DADA Dada Nexus | Target Lowered by | Mizuho Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $1.61 -5.3% | $4.50 ➝ $4.00 | Outperform ➝ Outperform | |
DAL Delta Air Lines | Target Raised by | TD Cowen Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $63.93 +0.6% | $59.00 ➝ $75.00 | Buy | |
DIS Walt Disney | Target Raised by | Evercore ISI Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $100.89 +0.0% | $105.00 ➝ $128.00 | Outperform ➝ Outperform | |
EE Excelerate Energy | Target Raised by | Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating | M. Blum Subscribe to MarketBeat All Access for the recommendation accuracy rating | $28.32 +1.5% | $19.00 ➝ $22.00 | Underweight ➝ Underweight | |
EOG EOG Resources | Reiterated by | Benchmark Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $133.05 0.0% | | Hold | |
FIVN Five9 | Downgraded by | Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $38.97 -1.8% | $55.00 ➝ $40.00 | Overweight ➝ Equal Weight | |
FMBH First Mid Bancshares | Downgraded by | DA Davidson Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $43.15 -0.1% | $44.00 ➝ $47.00 | Buy ➝ Neutral | |
FVR FrontView REIT | Initiated by | Capital One Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $18.88 -0.5% | $22.00 | Overweight | |
GENI Genius Sports | Reiterated by | Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $9.36 +15.8% | $9.00 ➝ $9.00 | Buy ➝ Buy | |
GRAB Grab | Reiterated by | Benchmark Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $4.72 +7.8% | $6.00 ➝ $6.00 | Buy ➝ Buy | |
GRAB Grab | Target Raised by | Evercore ISI Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $4.72 +7.8% | $7.00 ➝ $8.00 | Outperform ➝ Outperform | |
GSK GSK | Downgraded by | Jefferies Financial Group Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $35.49 -2.4% | $53.00 ➝ $39.50 | Buy ➝ Hold | |
HGV Hilton Grand Vacations | Target Lowered by | Mizuho Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $42.40 0.0% | $57.00 ➝ $55.00 | Outperform ➝ Outperform | |
HMN Horace Mann Educators | Downgraded by | Keefe, Bruyette & Woods Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $42.13 -0.4% | $39.00 ➝ $44.00 | Outperform ➝ Market Perform | |
HOOD Robinhood Markets | Target Raised by | JMP Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $33.21 +1.3% | $33.00 ➝ $40.00 | Market Outperform ➝ Market Outperform | |
HPP Hudson Pacific Properties | Downgraded by | Jefferies Financial Group Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $4.38 -1.4% | $5.50 ➝ $5.00 | Buy ➝ Hold | |
HWM Howmet Aerospace | Target Raised by | Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $114.57 -0.1% | $113.00 ➝ $129.00 | Overweight ➝ Overweight | |
IAC IAC | Reiterated by | Benchmark Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $49.93 -9.4% | $110.00 ➝ $110.00 | Buy ➝ Buy | |
IFF International Flavors & Fragrances | Upgraded by | Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $91.46 +0.3% | $111.00 ➝ $110.00 | Equal Weight ➝ Overweight | |
IHRT iHeartMedia | Upgraded by | Bank of America Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $2.56 +2.8% | $1.00 ➝ $3.00 | Underperform ➝ Neutral | |
ILMN Illumina | Reiterated by | Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $151.18 -0.2% | $156.00 | Equal Weight | |
ILMN Illumina | Target Raised by | Stephens Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $151.18 -0.2% | $170.00 ➝ $184.00 | Overweight ➝ Overweight | |
IMXI International Money Express | Target Raised by | Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $21.51 -0.4% | $22.00 ➝ $25.00 | Buy ➝ Buy | |
IPHA Innate Pharma | Reiterated by | HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $1.83 -1.4% | $11.50 ➝ $11.50 | Buy ➝ Buy | |
IVA Inventiva | Initiated by | UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $2.70 -2.5% | $3.00 | Neutral | |
IVAC Intevac | Reiterated by | Benchmark Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $2.59 -21.5% | | Hold | |
KIM Kimco Realty | Target Raised by | Robert W. Baird Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $25.04 -0.1% | $23.00 ➝ $26.00 | Outperform ➝ Outperform | |
KNX Knight-Swift Transportation | Downgraded by | Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating | A. Rosa Subscribe to MarketBeat All Access for the recommendation accuracy rating | $57.75 -1.9% | $56.00 ➝ $56.00 | Neutral ➝ Sell | |
KPRX Kiora Pharmaceuticals | Reiterated by | HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $3.80 +1.6% | $10.00 ➝ $10.00 | Buy ➝ Buy | |
KRG Kite Realty Group Trust | Target Raised by | KeyCorp Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $27.50 +0.2% | $28.00 ➝ $31.00 | Overweight ➝ Overweight | |
LGND Ligand Pharmaceuticals | Target Raised by | Royal Bank of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating | D. Miehm Subscribe to MarketBeat All Access for the recommendation accuracy rating | $123.81 +0.3% | $130.00 ➝ $140.00 | Outperform ➝ Outperform | |
LYEL Lyell Immunopharma | Reiterated by | HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating | M. Kapoor Subscribe to MarketBeat All Access for the recommendation accuracy rating | $1.15 -5.4% | $1.00 ➝ $1.00 | Neutral ➝ Neutral | |
LYV Live Nation Entertainment | Target Raised by | Benchmark Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $128.33 +3.7% | $132.00 ➝ $144.00 | Buy ➝ Buy | |
LYV Live Nation Entertainment | Target Raised by | Evercore ISI Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $128.33 +3.7% | $110.00 ➝ $150.00 | Outperform ➝ Outperform | |
MBLY Mobileye Global | Initiated by | Loop Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $16.57 -0.4% | $20.00 | Buy | |
MLYS Mineralys Therapeutics | Reiterated by | HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating | M. Caufield Subscribe to MarketBeat All Access for the recommendation accuracy rating | $13.90 -6.8% | $30.00 ➝ $30.00 | Buy ➝ Buy | |
MNDY monday.com | Target Raised by | Robert W. Baird Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $271.11 -1.5% | $265.00 ➝ $270.00 | Neutral ➝ Neutral | |
MNDY monday.com | Reiterated by | DA Davidson Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $271.11 -1.5% | $300.00 ➝ $300.00 | Neutral ➝ Neutral | |
MNDY monday.com | Target Raised by | Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $271.11 -1.5% | $300.00 ➝ $350.00 | Buy ➝ Buy | |
MNST Monster Beverage | Target Raised by | Argus Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $55.97 +0.4% | $55.00 ➝ $65.00 | Buy | |
MPWR Monolithic Power Systems | Reiterated by | Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $670.86 +3.6% | $950.00 ➝ $950.00 | Buy ➝ Buy | |
MTCH Match Group | Target Lowered by | Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $30.99 -3.0% | $36.00 ➝ $33.00 | Equal Weight ➝ Equal Weight | |
MTCH Match Group | Target Lowered by | KeyCorp Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $30.99 -3.0% | $45.00 ➝ $43.00 | Overweight ➝ Overweight | |
NCLH Norwegian Cruise Line | Target Raised by | Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $27.73 -0.3% | $19.00 ➝ $26.00 | Underweight ➝ Underweight | |
NEPH Nephros | Reiterated by | Benchmark Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $1.65 +2.5% | $5.00 ➝ $5.00 | Speculative Buy ➝ Speculative Buy | |
NGNE Neurogene | Target Raised by | Leerink Partners Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $41.02 -42.7% | $45.00 ➝ $72.00 | Outperform ➝ Outperform | |
NGNE Neurogene | Target Raised by | Robert W. Baird Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $41.02 -42.7% | $54.00 ➝ $72.00 | Outperform ➝ Outperform | |
NGNE Neurogene | Target Raised by | HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $41.02 -42.7% | $49.00 ➝ $55.00 | Buy ➝ Buy | |
NOW ServiceNow | Target Raised by | Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $1,036.69 +0.1% | $1,050.00 ➝ $1,150.00 | Overweight ➝ Overweight | |
NUTX Nutex Health | Target Raised by | Maxim Group Subscribe to MarketBeat All Access for the recommendation accuracy rating | A. Vendetti Subscribe to MarketBeat All Access for the recommendation accuracy rating | $34.63 +24.1% | $45.00 ➝ $50.00 | Buy | |
Central Bank Abandons USD (Ad) Startling new evidence shows the U.S. Central Bank is abandoning the currency we’ve relied on for centuries – the United States Dollar…
And placing a ‘quiet bet’ on a new type of currency…
Gold.
Click here now to get your free 'Protect Your Wealth' Guide. |
NUTX Nutex Health | Target Raised by | Benchmark Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $34.63 +24.1% | $45.00 ➝ $60.00 | Buy ➝ Buy | |
NVAX Novavax | Reiterated by | HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $8.26 -8.3% | $19.00 ➝ $19.00 | Buy ➝ Buy | |
NVDA NVIDIA | Initiated by | Redburn Atlantic Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $147.37 +1.5% | $178.00 | Buy | |
NVDA NVIDIA | Target Raised by | Mizuho Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $147.37 +1.5% | $140.00 ➝ $165.00 | Outperform ➝ Outperform | |
NVRO Nevro | Target Raised by | Robert W. Baird Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $6.15 +15.6% | $5.00 ➝ $6.00 | Neutral ➝ Neutral | |
NVRO Nevro | Target Lowered by | Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $6.15 +15.6% | $7.00 ➝ $6.00 | Underweight ➝ Underweight | |
ODFL Old Dominion Freight Line | Downgraded by | Argus Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $230.41 -0.6% | | Buy ➝ Hold | |
OKTA Okta | Downgraded by | Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $78.46 +0.0% | $115.00 ➝ $85.00 | Buy ➝ Hold | |
OS Onestream | Target Raised by | Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $33.81 -1.5% | $35.00 ➝ $37.00 | Equal Weight ➝ Equal Weight | |
PAR PAR Technology | Target Raised by | Benchmark Subscribe to MarketBeat All Access for the recommendation accuracy rating | M. Palmer Subscribe to MarketBeat All Access for the recommendation accuracy rating | $75.38 +0.3% | $69.00 ➝ $92.00 | Buy ➝ Buy | |
PHUN Phunware | Downgraded by | HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $5.36 -10.5% | $9.00 ➝ $6.00 | Buy ➝ Neutral | |
PLYM Plymouth Industrial REIT | Target Lowered by | Robert W. Baird Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $20.64 -1.1% | $26.00 ➝ $25.00 | Outperform ➝ Outperform | |
RAPT RAPT Therapeutics | Reiterated by | HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $1.75
| | Neutral | |
RAPT RAPT Therapeutics | Target Lowered by | Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $1.75
| $17.00 ➝ $4.00 | Overweight ➝ Overweight | |
ROST Ross Stores | Downgraded by | Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $141.49 -0.6% | $179.00 ➝ $152.00 | Buy ➝ Neutral | |
RRR Red Rock Resorts | Reiterated by | Mizuho Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $52.01 -1.0% | $67.00 ➝ $57.00 | Outperform ➝ Outperform | |
RXO RXO | Downgraded by | Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating | A. Rosa Subscribe to MarketBeat All Access for the recommendation accuracy rating | $28.20 -4.1% | $33.00 ➝ $33.00 | Buy ➝ Neutral | |
S SentinelOne | Upgraded by | Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $27.63 +1.7% | $25.00 ➝ $32.00 | Hold ➝ Buy | |
SGMT Sagimet Biosciences | Initiated by | UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $5.84 -0.2% | $12.00 | Buy | |
SLRC SLR Investment | Target Raised by | Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $15.93 -1.1% | $12.50 ➝ $13.00 | Underweight ➝ Underweight | |
SNDR Schneider National | Downgraded by | Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating | A. Rosa Subscribe to MarketBeat All Access for the recommendation accuracy rating | $31.49 -1.1% | $32.00 ➝ $30.00 | Neutral ➝ Sell | |
SPNS Sapiens International | Target Lowered by | Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $29.39 +1.0% | $44.00 ➝ $35.00 | Buy ➝ Buy | |
SUI Sun Communities | Downgraded by | Bank of America Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $124.21 -2.3% | $147.00 ➝ $114.00 | Neutral ➝ Underperform | |
TALO Talos Energy | Reiterated by | Benchmark Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $11.99 +1.9% | $20.00 ➝ $20.00 | Buy ➝ Buy | |
TCBK TriCo Bancshares | Downgraded by | DA Davidson Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $48.88 -0.1% | $50.00 ➝ $53.00 | Buy ➝ Neutral | |
TCOM Trip.com Group | Target Raised by | Mizuho Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $63.67 -4.5% | $65.00 ➝ $78.00 | Outperform ➝ Outperform | |
TECX Tectonic Therapeutic | Target Raised by | Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating | T. Fauth Subscribe to MarketBeat All Access for the recommendation accuracy rating | $44.90 -2.5% | $55.00 ➝ $79.00 | Overweight ➝ Overweight | |
TPB Turning Point Brands | Target Raised by | Benchmark Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $52.74 +0.5% | $45.00 ➝ $65.00 | Buy ➝ Buy | |
TSHA Taysha Gene Therapies | Reiterated by | Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $2.04 +25.2% | $6.00 ➝ $6.00 | Buy ➝ Buy | |
TSHA Taysha Gene Therapies | Reiterated by | Cantor Fitzgerald Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $2.04 +25.2% | $7.00 ➝ $7.00 | Overweight ➝ Overweight | |
TWLO Twilio | Upgraded by | Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $97.67 +3.8% | $80.00 ➝ $120.00 | Equal Weight ➝ Overweight | |
UNCY Unicycive Therapeutics | Reiterated by | HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $0.51 -3.6% | $2.50 ➝ $2.50 | Buy ➝ Buy | |
VAC Marriott Vacations Worldwide | Target Raised by | Mizuho Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $93.26 -0.9% | $110.00 ➝ $117.00 | Outperform ➝ Outperform | |
VEON VEON | Initiated by | Benchmark Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $33.33 +0.5% | $48.00 | Buy | |
VIK Viking | Upgraded by | Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $45.88 +3.2% | $37.00 ➝ $49.00 | Equal Weight ➝ Overweight | |
VRE Veris Residential | Upgraded by | Bank of America Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $18.54 +2.5% | $20.00 ➝ $23.00 | Neutral ➝ Buy | |
WMT Walmart | Target Raised by | Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $85.04 +1.0% | $82.00 ➝ $89.00 | Overweight ➝ Overweight | |
ZETA Zeta Global | Target Raised by | Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $32.22 -12.3% | $36.00 ➝ $43.00 | Buy ➝ Buy | |
ZETA Zeta Global | Target Raised by | Oppenheimer Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $32.22 -12.3% | $33.00 ➝ $42.00 | Outperform ➝ Outperform | |